Published January 17, 2018 | Version v1
Dataset Open

Generation of fluorescently labelled OP9 stromal cells for growing patient leukemic cells

Creators

  • 1. Structural Genomics Consortium, Princess Margaret Cancer Centre, University Health Network
  • 2. Structural Genomics Consortium, University of Toronto
  • 3. Princess Margaret Cancer Centre, University Health Network, University of Toronto
  • 4. Structural Genomics Consortium, Princess Margaret Cancer Centre, University Health Network, University of Toronto

Description

We added fluorescent labels to OP9 stromal cells to allow us to easily distinguish stromal cells from primary leukemia cells in co-culture growth conditions.

Notes

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z]. This project receives funding from the Leukemia and Lymphoma Society of Canada.

Files

01-17-18_fluorescent_OP9_zenodo_gl.pdf

Files (4.1 MB)

Name Size Download all
md5:aa6f5cf2ad3f877902fb4a574b3012e5
3.6 MB Download
md5:79b5bedb029921a200211d0ba7cccc96
528.1 kB Preview Download